AKT1 and Hepatic fibrosis: By modifying or inhibiting the PI3K/AKT/mTOR pathway, various potential inhibitors, such as some natural compounds, offer the ability to prevent HSC activation and liver fibrosis.62, 63, 64, 65, 66, 67